PDCD1 and renal cell carcinoma: Understanding these interconnected networks between PD-1 immunology and distinct cell populations related to renal cell carcinoma, glomerulonephritis, kidney transplantation, or renal aging will be critical to the development of novel drugs targeting PD-1 signaling.